A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Clinical trial NCT06131840 · RECRUITING

Trial details

NCT number: NCT06131840
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Stomach Neoplasms Pancreatic Ductal Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Small Cell Lung Carcinoma

Start date: 2023-11-20
Primary completion: 2029-09-12
Enrollment: 914

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.